Apolipoprotein E ɛ2 and Functional Decline in Amnestic Mild Cognitive Impairment and Alzheimer Disease
Year: 2011
Type: article
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Alzheimer's Association, Dana Foundation, Abbott Laboratories, Bristol-Myers Squibb, Alzheimer's Drug Discovery Foundation, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Merck, Novartis, Roche, Schering-Plough, Synarc, Alzheimer's Disease Neuroimaging Initiative, Elan, Innogenetics, Bayer Schering, National Institutes of Health, U.S. Food and Drug Administration, Genentech, Johnson and Johnson, GE Healthcare, National Institute on Aging, National Institute of Biomedical Imaging and Bioengineering
OpenAlex ID: W2076370468
